Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
partnership
Pharma
InflaRx may find path forward for COVID drug in skin disorder
Positive post hoc analyses could prompt InflaRx to revive development of its COVID med vilobelimab in the rare skin disorder pyoderma gangrenosum.
Fraiser Kansteiner
Jan 2, 2026 10:25am
J&J signs on as the New York Jets' medical innovation sponsor
Oct 22, 2025 2:55pm
Sobi places $300M bet on Empaveli in partnership with Apellis
Jul 1, 2025 11:28am
AbbVie flies the W against cancer with Chicago Cubs partnership
May 30, 2025 10:57am
Sanofi eyes Vietnam vaccine production amid tech transfer deal
May 27, 2025 2:45pm
Eurovision sponsor Novartis links music, science in new campaign
Mar 21, 2025 11:42am
